Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-09-10

Clinical Trial Update: Oxandrolone Compared With a Placebo on Growth Rate in Girls With Growth Hormone-Treated Turner's Syndrome [Phase 2]

View source ↗

Summary

This Phase 2 trial compares oxandrolone to placebo for growth rate in girls with Turner syndrome receiving growth hormone; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxandrolone (Oxandrolone)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Turner's Syndrome | Phase 2 | Status: COMPLETED